APT Medical Inc.
688617
株式のランク
#3232
APT Medical Inc. is a global enterprise dedicated to the research, development,... APT Medical Inc. is a global enterprise dedicated to the research, development, production, and commercialization of invasive interventional medical devices primarily targeting cardiovascular and cerebrovascular diseases. Its extensive product portfolio encompasses a range of electrophysiological tools, including catheter delivery systems, alongside radiofrequency ablation and mapping catheters. Additionally, APT Medical provides various vascular intervention solutions, spanning diagnostic and therapeutic devices, as well as essential intervention accessories. Beyond its proprietary offerings, the company extends its expertise through OEM (Original Equipment Manufacturer) and ODM (Original Design Manufacturer) services for catheter and metal-based products, including associated accessories. Established in 2002, APT Medical maintains its corporate headquarters in Shenzhen, China.
株価
$38.62
時価総額
$5.47B
変化（1日）
0.19%
変化（1年）
-17.07%
国
CN
取引 APT Medical Inc. (688617)
カテゴリー
Healthcare
APT Medical Inc.（688617）のP/B比率
October 2026 時点のP/B比率 TTM: 11.63
APT Medical Inc. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 11.63 です。2024 年末時点でのP/B比率は 14.39 でした。
APT Medical Inc. の P/B 比率の履歴（2017 ～ 2026）
各年末時点のP/B比率
| 年 | P/B比率 | 変化 |
|---|---|---|
| 2026 (TTM) | 11.63 | 4.68% |
| 2025 | 11.11 | -22.84% |
| 2024 | 14.39 | 6.81% |
| 2023 | 13.48 | 14.62% |
| 2022 | 11.76 | 13.84% |
| 2021 | 10.33 | -74.43% |
| 2020 | 40.40 | -24.28% |
| 2019 | 53.35 | -22.79% |
| 2018 | 69.10 | -20.58% |
| 2017 | 87.00 | 0.00% |
同業他社のP/B比率
| 企業 | P/B比率 | P/B比率の差 | 国 |
|---|---|---|---|
| 3.4297 | -70.51% |
US
|
|
| 2.4161 | -79.22% |
IE
|
|
| 4.9278 | -57.63% |
US
|
|
| 2.6381 | -77.32% |
US
|
|
| 2.4467 | -78.96% |
DE
|
